Overview

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-11-01

Target enrollment:

Participant gender:

Summary

The study is to evaluate the efficacy and safety of AHB-137 in CHB participants. The total duration of the study, including screening phase, treatment phase and follow-up phase.

Phase:

PHASE2

Details

Lead Sponsor:

Ausper Biopharma Co., Ltd.

Treatments:

nas